Literature DB >> 19220627

Decreased Srcasm expression in hyperproliferative cutaneous lesions.

Marc C Meulener1, Elias E Ayli, Rosalie Elenitsas, John T Seykora.   

Abstract

BACKGROUND: Src-family tyrosine kinases (SFKs) are signaling proteins that regulate keratinocyte proliferation and differentiation. Src-activating and signaling molecule (Srcasm) is a recently identified molecule that downregulates SFK activity and promotes keratinocyte differentiation. To determine if Srcasm expression correlates with keratinocyte differentiation, we characterized the level of Srcasm expression in some cutaneous lesions that exhibit increased keratinocyte proliferation.
METHODS: Formalin-fixed sections of randomly selected seborrheic keratoses (SKs) and basal cell carcinomas (BCCs) were analyzed for Srcasm and Ki-67 immunohistochemical staining. Anti-Srcasm and anti-Ki-67 stainings were performed in parallel.
RESULTS: All SKs displayed decreased Srcasm staining in areas comprised of basaloid keratinocytes that exhibited an increased Ki-67 index. Higher Srcasm staining levels were detected near pseudohorn cysts where keratinocytes exhibited a lower Ki-67 index. All multicentric and nodular BCCs displayed a prominent loss of Srcasm staining in association with a marked increase in Ki-67 staining.
CONCLUSIONS: Our results support the hypothesis that Srcasm protein levels are decreased in the hyperproliferative keratinocytes found in SKs and BCCs. Increased Srcasm protein levels are detected in keratinocytes undergoing differentiation. Decreased Srcasm levels may be part of the pathophysiologic mechanism in cutaneous lesions, exhibiting keratinocyte hyperproliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19220627      PMCID: PMC3099410          DOI: 10.1111/j.1600-0560.2008.01035.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  14 in total

Review 1.  Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase.

Authors:  Richard L Eckert; Tatiana Efimova; Shervin R Dashti; Sivaprakasam Balasubramanian; Anne Deucher; James F Crish; Michael Sturniolo; Frederic Bone
Journal:  J Investig Dermatol Symp Proc       Date:  2002-12

2.  Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.

Authors:  Christian Hafner; Elena López-Knowles; Nuno M Luis; Agustí Toll; Eulàlia Baselga; Alex Fernández-Casado; Silvia Hernández; Adriana Ribé; Thomas Mentzel; Robert Stoehr; Ferdinand Hofstaedter; Michael Landthaler; Thomas Vogt; Ramòn M Pujol; Arndt Hartmann; Francisco X Real
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-02       Impact factor: 11.205

3.  'Srcasm: a novel Src activating and signaling molecule.

Authors:  John T Seykora; Lijuan Mei; G Paolo Dotto; Paul L Stein
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

4.  Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.

Authors:  R A Abdelsayed; M Guijarro-Rojas; N A Ibrahim; O P Sangueza
Journal:  J Cutan Pathol       Date:  2000-04       Impact factor: 1.587

5.  Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.

Authors:  H Onodera; S Nakamura; T Sugai
Journal:  Am J Dermatopathol       Date:  1996-12       Impact factor: 1.533

6.  Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma.

Authors:  Ozlem Yerebakan; Mehmet Akif Ciftçioglu; Bahar Kiliçarslan Akkaya; Ertan Yilmaz
Journal:  J Dermatol       Date:  2003-01       Impact factor: 4.005

7.  Srcasm modulates EGF and Src-kinase signaling in keratinocytes.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Leonard Dzubow; Chrysalene Schmults; Michael Dans; John Seykora
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

8.  fyn tyrosine kinase is involved in keratinocyte differentiation control.

Authors:  E Calautti; C Missero; P L Stein; R M Ezzell; G P Dotto
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

Review 9.  Familial basaloid follicular hamartoma: lesional characterization and review of the literature.

Authors:  Debra M Jih; Michael Shapiro; William D James; Marc Levin; Joel Gelfand; Patrick T Williams; Rebecca J Oakey; Steven Fakharzadeh; John T Seykora
Journal:  Am J Dermatopathol       Date:  2003-04       Impact factor: 1.533

10.  Patterns of epidermal growth factor receptors in basal and squamous cell carcinoma.

Authors:  E A Springer; J K Robinson
Journal:  J Dermatol Surg Oncol       Date:  1991-01
View more
  3 in total

1.  Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.

Authors:  Yu Qi; Xin Li; Liang Zhao; John T Seykora
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

2.  Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Authors:  Liang Zhao; Weijie Li; Christine Marshall; Thomas Griffin; Matthew Hanson; Ryan Hick; Tzvete Dentchev; Erik Williams; Adrienne Werth; Christopher Miller; Hasan Bashir; Warren Pear; John T Seykora
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

3.  Downregulation of Src-family tyrosine kinases by Srcasm and c-Cbl: A comparative analysis.

Authors:  Vivian Lee; Thomas D Griffin; Yoko Suzuki-Horiuchi; Lily Wushanley; Yerin Kweon; Christine Marshall; Weijie Li; Elias Ayli; Adele Haimovic; Aliya Hines; John T Seykora
Journal:  J Carcinog       Date:  2021-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.